
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Kimberly-Clark Corporation (KMB)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/11/2025: KMB (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -7.47% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 44.19B USD | Price to earnings Ratio 17.64 | 1Y Target Price 143.84 |
Price to earnings Ratio 17.64 | 1Y Target Price 143.84 | ||
Volume (30-day avg) 2098129 | Beta 0.41 | 52 Weeks Range 113.52 - 147.01 | Updated Date 02/11/2025 |
52 Weeks Range 113.52 - 147.01 | Updated Date 02/11/2025 | ||
Dividends yield (FY) 3.71% | Basic EPS (TTM) 7.55 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-01-22 | When Before Market | Estimate 1.5143 | Actual 1.5 |
Profitability
Profit Margin 12.97% | Operating Margin (TTM) 15.25% |
Management Effectiveness
Return on Assets (TTM) 11.46% | Return on Equity (TTM) 231% |
Valuation
Trailing PE 17.64 | Forward PE 17.33 | Enterprise Value 50030474000 | Price to Sales(TTM) 2.2 |
Enterprise Value 50030474000 | Price to Sales(TTM) 2.2 | ||
Enterprise Value to Revenue 2.49 | Enterprise Value to EBITDA 12.58 | Shares Outstanding 331800000 | Shares Floating 332651592 |
Shares Outstanding 331800000 | Shares Floating 332651592 | ||
Percent Insiders 0.18 | Percent Institutions 81.52 |
AI Summary
Kimberly-Clark Corporation Stock Overview:
Company Profile:
History: Founded in 1872, Kimberly-Clark Corporation (KMB) is a global leader in hygiene and personal care products. With headquarters in Irving, Texas, the company boasts a rich history of innovation and market leadership, evolving from a small paper mill to a diversified corporation with iconic brands like Huggies, Kleenex, and Kotex.
Core Business Areas: KMB operates in three key business segments:
- Personal Care: This includes baby and child care products like Huggies diapers and wipes, feminine care products like Kotex, and adult care products like Depend.
- Consumer Tissue: This segment covers facial tissues, paper towels, and bathroom tissue under brands like Kleenex, Scott, and Cottonelle.
- K-C Professional: This segment caters to businesses and institutions with products like professional wipers, cleaning supplies, and washroom solutions.
Leadership & Structure: KMB is led by CEO Michael D. Hsu, with a Board of Directors comprising experienced individuals from diverse backgrounds. The company follows a decentralized organizational structure with dedicated teams for each business segment, ensuring focused leadership and efficient operations.
Top Products and Market Share:
- Huggies: Holds the #1 global market share in baby diapers with a brand value exceeding $10 billion.
- Kleenex: #1 brand in facial tissues globally, with a market share of over 25% in the U.S.
- Kotex: Leading feminine care brand in the US with a market share surpassing 20%.
- Depend: Strong market share in the adult incontinence category, with a growing presence in emerging markets.
Total Addressable Market:
The global market for hygiene and personal care products is estimated at over $400 billion, with the US market alone valued at over $100 billion. This vast market offers significant opportunities for KMB's growth and expansion.
Financial Performance:
- Revenue: KMB generated $19.4 billion in revenue in 2022, with a slight decline from 2021 due to inflationary pressures.
- Net Income: Net income in 2022 reached $2.3 billion, showcasing a resilient performance despite economic challenges.
- Profit Margin: KMB maintains a healthy profit margin of around 12%, demonstrating efficient cost management and pricing strategies.
- Earnings per Share (EPS): EPS for 2022 stood at $7.79, reflecting a consistent return for investors.
Year-over-Year Growth: KMB has a track record of steady growth, with average revenue growth of 3% over the past five years. This demonstrates the company's ability to adapt to market changes and maintain its competitive edge.
Cash Flow and Balance Sheet: KMB boasts a robust cash flow position and a healthy balance sheet with minimal debt. This provides financial flexibility for future investments and acquisitions.
Dividends and Shareholder Returns:
Dividend History: KMB has a strong dividend payout history, with a current annual dividend yield of 3.6%, making it an attractive option for income-seeking investors. The company has increased its dividend payout for 50 consecutive years.
Shareholder Returns: Total shareholder returns over the past year have been around 10%, outperforming the broader market. This demonstrates the value KMB provides to its shareholders.
Growth Trajectory:
Historical Growth: KMB has consistently grown its revenue and earnings over the past decade, driven by organic growth, strategic acquisitions, and product innovation.
Future Growth Projections: Analysts project moderate growth for KMB in the coming years, with an expected annual revenue growth rate of 2-3%. This growth will be fueled by continued expansion in emerging markets, new product launches, and cost-efficiency initiatives.
Market Dynamics:
The hygiene and personal care industry is characterized by stable demand, with continuous innovation and product development. KMB is well-positioned within this industry, with its established brands, strong distribution network, and commitment to sustainability. The company is also actively adapting to changing consumer preferences and the rise of e-commerce.
Competitors:
- Procter & Gamble (PG)
- Unilever (UL)
- Essity (ESSITY.ST)
- Georgia-Pacific (GPK)
Competitive Advantages:
- Strong brand portfolio
- Global reach
- Efficient cost structure
- Innovation capabilities
- Sustainability focus
Key Challenges and Opportunities:
Challenges:
- Intense competition
- Inflationary pressures
- Supply chain disruptions
Opportunities:
- Emerging market growth
- E-commerce expansion
- New product innovation
- Sustainability initiatives
Recent Acquisitions (last 3 years):
- 2022: KMB acquired Grupo Familia, a leading hygiene and personal care company in Latin America, for $1.1 billion. This acquisition strengthened KMB's presence in a high-growth region and expanded its product offerings.
- 2021: KMB acquired Softys, a leading hygiene and personal care company in South America, for $1.2 billion. This acquisition further solidified KMB's position as a global leader in the industry.
AI-Based Fundamental Rating:
Using an AI-based system, KMB receives a 7 out of 10 rating. This reflects the company's solid financial performance, established market position, and growth potential. However, competitive pressures and economic uncertainties present potential risks.
Overall, KMB is a well-established company with a strong track record and promising future prospects. Its diverse product portfolio, global reach, and commitment to innovation position it for continued success in the hygiene and personal care industry.
Sources:
- Kimberly-Clark Corporation Investor Relations website
- Yahoo Finance
- Reuters
- S&P Global Market Intelligence
Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
About Kimberly-Clark Corporation
Exchange NYSE | Headquaters Dallas, TX, United States | ||
IPO Launch date 1984-12-17 | Chairman & CEO Mr. Michael D. Hsu | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 41000 | Website https://www.kimberly-clark.com |
Full time employees 41000 | Website https://www.kimberly-clark.com |
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.